Sino Biological,Inc. (SHE:301047)

China · Delayed Price · Currency is CNY

63.00

+2.63 (4.36%)

At close: Jun 23, 2026

2.21% (1Y)

Market Cap	7.34B -3.4%
Revenue (ttm)	727.69M +18.0%
Net Income	157.25M +56.0%
EPS	1.29 +61.7%
Shares Out	121.64M
PE Ratio	46.70
Forward PE	n/a
Dividend	5.20 (8.58%)
Ex-Dividend Date	May 15, 2026

Volume	1,662,966
Open	60.07
Previous Close	60.37
Day's Range	60.00 - 64.19
52-Week Range	58.05 - 85.00
Beta	0.72
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Sino Biological,Inc.

Sino Biological,Inc. engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally. The company offers recombinant proteins, antibodies, cDNA clones, kits, serum-free media, protein modification, qPCR primers, cell lysates, and purification reagents. It also provides comprehensive solutions, including autoimmune disease research, kinase drug discovery, cytokine and growth factor, SARS-CoV-2 variants research, comprehensive CAR-T therapy, 3D organoids research, ADC development, in... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2016

Employees 1,069

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301047

Full Company Profile

Financial Performance

In 2025, Sino Biological,Inc.'s revenue was 699.56 million, an increase of 14.00% compared to the previous year's 613.67 million. Earnings were 147.74 million, an increase of 21.17%.

Financial Statements